Cyclo(His-Phe) was effectively converted to its dehydro derivatives by the enzyme of Streptomyces albulus KO-23, an albonoursin-producing actinomycete. Two types of dehydro derivatives were isolated from the reaction mixture and identified as cyclo(ÁHis-ÁPhe) and cyclo(His-ÁPhe). This is the first report on cyclo-(His-ÁPhe) and the enzymatic preparation of both compounds. Cyclo(ÁHis-ÁPhe), a tetradehydro cyclic dipeptide, exhibited a minimum inhibitory concentration of 0.78 mol/ml inhibitory activity toward the first cleavage of sea urchin embryos, in contrast to cyclo-(His-ÁPhe) that had no activity. The finding that the isoprenylated derivative of cyclo(ÁHis-ÁPhe), dehydrophyenylahistin, had 2,000 times higher activity than cyclo(ÁHis-ÁPhe) indicates that an isoprenyl group attached to an imidazole ring of the compound was essential for the inhibitory activity.
Cyclic dipeptides (CDPs), diketopiperazine ring-containing compounds, are widely distributed in nature, and their dehydro derivatives are known to exhibit unique bioactivities. 1) We have previously reported that Streptomyces albulus KO-23 had a biosynthetic enzyme converting cyclo(L-Leu-L-Phe), CFL, to its dehydro derivative albonoursin, 2, 3) and that the enzyme effectively catalyzed the bioconversion of CAF, CFF, CFG and CFV to their corresponding dehydro CDPs. 4) We have recently prepared a novel dehydro CDP dehydrophenylahistin (ÁPLH; 2) from fungal metabolite (À)-phenylahistin ((À)-PLH; 1) by the use of this enzyme. 5) ÁPLH (2) exhibited potent cytotoxic activity and higher than that of the known anticancer drugs, taxol, vinblastine and vincristine, indicating that this novel compound could be a candidate for an anticancer drug. 5) Although there is not much difference in structure between ÁPLH [cyclo(ÁisoprenylHis-ÁPhe)] (2) and (À)-PLH [cyclo(ÁisoprenylHis-L-Phe)] (1) (Fig. 1) , ÁPLH exhibited more than 1000 times the inhibitory activity toward the first cleavage of sea urchin embryos y To whom correspondence should be addressed. Fax: +81-86-251-8388; E-mail: hkanzaki@cc.okayama-u.ac.jp Abbreviations: CDP, cyclic dipeptide; CFL, cyclo(Leu-Phe); CAF, cyclo(Ala-Phe); CFG, cyclo(Gly-Phe); CFV, cyclo(Phe-Val); PLH, phenylahistin; ÁPLH, dehydrophenylahistin as (À)-PLH (1). Thus, structure-activity relationship studies are needed to develop ÁPLH and its analogs as anticancer drugs.
This paper describes enzymatic preparation of the dehydro derivatives of cyclo(His-Phe), CFH (3), which has no isoprenyl group, in contrast to PLH (1) and ÁPLH (2) , which has such a group, and a comparison of their activities to those of PLH (1) and ÁPLH (2).
Materials and Methods
Materials. CFH (3) was obtained from Bachem AG (Switzerland). All other reagents were commercially available.
Enzyme preparation and assay. Cultivation of the albonoursin-producing strain, S. albulus KO-23, and preparation of its cell-free extract were carried out by the methods described in our previous paper.
4 ) The CFL dehydrogenation activity was measured by the cofactorcoupling assay; 5) one unit of the activity is defined as the amount of enzyme that catalyzes the formation of one mole of albonoursin per minute, which equals to the reduction of two mole of dichlorophenol indophenol, under the standard conditions for the cofactor-coupling assay.
Analytical methods.
1 H-NMR spectra were recorded in CDCl 3 or DMSO-d 6 with a Varian VXR-500 instrument, while UV and mass spectra were respectively obtained with Shimadzu UV-3000 and JEOL SX-102A instruments. The conversion was monitored by ODS-HPLC: column, Inertsil ODS-3 (4:6 Â 250 mm, GL Sciences); solvent, 65% methanol; flow rate, 1.0 ml/ min; detection, single wavelength UV detector (256 nm, Waters LC-module 1) or diode array detector (Hitachi L-7455, UV 200-400 nm).
Bioconversion of CFH. The reaction mixture contained 0.05 mol of a substrate (10 l of DMSO), 0.9 mol of a sodium phosphate buffer (pH 8.0) and 0.0145 units of the enzyme in a final volume of 100 l. The reaction was carried out at 50 C for 24 hrs and stopped by adding 900 l of MeOH. The conversion process was monitored by HPLC as just described above.
Isolation of the CFH dehydrogenation products. Fifty mg of CFH (3) was treated with a cell-free extract containing 4.35 units of the enzyme in 100 ml of the reaction mixture at pH 8.0 and 50 C for 24 hrs with shaking.
After centrifuging the reaction mixture, the supernatant was extracted with EtOAc. The EtOAc extract (11.5 mg) was subjected to preparative HPLC (ODS-3 column, 20 Â 250 mm, GL Sciences), eluting with 60% methanol [10.0 ml/min flow rate, 5-ml fractions]. This operation gave 1.15 and 2.27 mg of pure compounds 5 and 6, respectively. The remaining watersoluble fraction after EtOAc extraction was concentrated to dryness, and the resulting residue (35.9 mg) was extracted with 70% MeOH. The 70% MeOH extract was subjected to preparative HPLC under the same conditions as those just described above, giving 2.33 mg of pure compound 4.
Bioassay for cytotoxicity. The method for assaying the cytotoxicity toward sea urchin embryos was as previously described.
6) Three species of sea urchins, Hemicentrotus pulcherrimus, Scaphechinus mirabilis, and Temnopleurus toreumaticus, were used for the bioassay. The first cleavage of sea urchin embryos was blocked when treated at doses higher than MID (minimum inhibitory dose).
Results

Enzymatic conversion of CFH
The enzyme converting CFL to albonoursin exhibited a wide substrate specificity for cyclic dipeptides, especially those containing a Phe residue, including PLH [cyclo(ÁisoprenylHis-Phe)], a CFH analog, indicating that CFH was possibly converted to its dehydro derivatives.
The enzymatic conversion of CFH by a cell-free extract of S. albulus KO23 was carried out under the optimum pH (8.0) and temperature (50 C) for albonoursin synthesis. After a 24-hr reaction, three newly produced compounds were detected at tR 4.0 (compound 4), 9.2 (compound 5) and 11.7 min (compound 6) in the HPLC chromatogram. No conversion was apparent when using a heat-denatured cell-free extract, indicating that compounds 4-6 had been formed by an enzymatically catalyzed reaction. The UV spectrum of compound 6 obtained by repetitive HPLC analyses with seven different single-wavelength detection (256, 300, 320, 340, 360, 380 and 400 nm) was very similar to that of ÁPLH, suggesting this compound to be CÁFÁH, a tetradehydro derivative, and that compound 5, which exhibited the same UV spectrum as that of compound 6, might be a geometrical isomer of compound 6. The UV absorption maximum at near 300 nm of compound 4 is very similar to that at 307 nm of CÁFL, 7) indicating that 4 might be CÁFH, a didehydro derivative of CFH.
Enzymatic preparation of compounds 4, 5 and 6
The optimum reaction conditions were first examined for preparaing the products from CFH. The substrate concentration was fixed at 0.5 mg/ml, the same as that for the optimum production of albonoursin and ÁPLH. The combination of two different enzyme concentrations, 0.145 units/ml and 0.435 units/ml, and two different reaction temperatures, 30 and 50 C, was tested. The production of compound 6 was highest at 50 C when using 0.435 units/ml of the enzyme, while the reaction rate and the amount of product 4 were similar under these four conditions. Thus, the optimum reaction conditions for preparing the CFH dehydro products were determined to be 0.435 units/ml of the enzyme and 50 C. Compound 5 could hardly be detected in any sample just after the reaction, but gradually increased with the decrease of compound 6. This phenomenon strongly supports compound 5 being a geometrical isomer of compound 6.
Fifty
An EI-mass analysis of compound 6 revealed that it had a molecular weight of 280, four mass units lower than that of CFH, indicative of a tetradehydro derivative of CFH. This was confirmed by the molecular formula of C 15 H 12 O 2 N 4 obtained by HREIMS measurements (Table 1 ). The UV spectrum of this compound ( max , nm ("): 205 (14,800), 351 (27,100)) was similar to that of ÁPLH ( max , nm ("): 205 (16,600), 363 (35,300)). In its 1 H-NMR spectrum, the presence of two olefinic protons at 6.77 and 7.02 and the loss of both -protons in the Phe and His residues of CFH strongly suggested that compound 6 was CÁFÁH. The NOESY analysis gave observed NOE between the NH proton in the ÁPhe residue ( 8.09) and the phenyl proton ( 7.37), and not between the NH proton and the olefinic proton ( 7.02), indicating the geometry of the double bond in the ÁPhe residue to be Z. The amide NH proton in the ÁHis residue was observed at a relatively low magnetic field, 11.91, indicating the presence of a hydrogen bond between this proton and the imidazole nitrogen. NOE was not observed between the NH proton ( 11.91) and the olefinic proton ( 6.77) in the ÁHis residue. These data indicate the geometry of the double bond in the ÁHis residue to be Z. Compound 6 was identified from these data as 3Z-benzylidene-6Z-(1H-imidazol-4-ylmethylene)-2,5-piperazinedione (Z,Z-CÁFÁH) (Fig. 2) .
The fractions containing pure compound 5 after preparative HPLC were combined and concentrated in vacuo. An HPLC analysis of the concentrate revealed that it contained both compounds 5 and 6 in the ratio of 1:1. We have previously reported that ÁPhe-containing dehydro cyclic dipeptides were enzymatically synthesized in Z-form and gradually converted to E-form by a non-enzymatic process.
5,7) Compound 5 was assumed from these data to be a geometrical isomer of compound 6, and possibly 3E-benzylidene-6Z-(1H-imidazol-4-ylmethylene)-2,5-piperazinedione (E,Z-CÁFÁH).
The molecular weight of compound 4 was found to be 2 mass units lower than that of CFH, indicative of a didehydro derivative of CFH. This indication was confirmed by the molecular formula C 15 H 14 O 2 N 4 obtained from HREIMS measurements ( Table 1 ). The UV spectrum of this compound ( max , nm ("): 210 (13,500), 298 (12,600)) was similar to that of CÁFL ( max , nm ("): 224 (9,300), 307 (13,100)), suggesting that it was a ÁPhe-containing dehydro cyclic dipeptide. Only one olefinic proton was observed in its 1 H-NMR spectrum, in contrast with two protons in that of compound 6. All signals in the spectrum were assigned to protons of CÁFH. NOE was observed between the NH proton in the Phe residue ( 9.76) and the benzene proton ( 7.40), but not between the NH proton and olefinic proton ( 6.49), indicating that the geometry of the double bond in the ÁPhe residue was Z. Compound 4 was identified from these data as 3Z-benzylidene-6Z-(1H-imidazol-4-ylmethyl)-2,5-piperazinedione (Z-CÁFH) (Fig. 2) .
Inhibitory activity toward the first cleavage of sea urchin embryos
As shown in Table 2 , CÁFÁH exhibited more than 8 times higher inhibitory activity toward the first cleavage of sea urchin (Hemicentrotus pulcherrimus, Scaphechinus mirabilis or Temnopleurus toreumaticus) embryos than albonoursin, while CFH and CÁFH had no activity. Among these three sea urchins tested, H. pulcherrimus was found to be more sensitive to dehydro CDPs than other two sea urchins.
Discussion
We have reported here the preparation and identification of the dehydro derivatives of cyclo(His-Phe). This is the first report on the preparation of CÁFH. An enzymatic preparation of CÁFÁH has also never been reported before, although its organic synthesis has been achieved by Xenova Ltd. in their patent application. 8) Xenova Ltd. has reported that the dehydro CDPs exhibited inhibitory activity against a plasminogen activator inhibitor, so the dehydro CDPs prepared by our enzymatic system could possibly exhibit the same activity.
Among the cyclo(His-Phe) analogs, tetradehydro derivative CÁFÁH exhibited inhibitory activity against cell division, while cyclic dipeptide CFH and didehydro derivative CÁFH did not (Table 1 ). This result confirmed our speculation that the presence of double bonds at the ,-positions in both amino acid residues of CDPs was required for high inhibitory activity. 4) We have previously reported that ÁPLH exhibited potent inhibitory activity toward cell division.
3) Although CÁFÁH prepared in this study was structurally similar to ÁPLH, which has an isoprenyl group attached to an imidazol ring while CÁFÁH has not, its activity was 2,000 times less than that of ÁPLH. Kanoh et al. have reported that the activities of PLH analogs with a methyl group instead of an isoprenyl group were lower than that of PLH. 9) These results indicate the presence of the isoprenyl group to be attributable to the expression of the higher activity of ÁPLH. In summary, the high inhibitory activity of ÁPLH is attributable to the following three structural units: (1) a uniplanar pseudo three-ring structure formed by the hydrogen bonding of diketopiperazine and imidazole rings, (2) the further widespread planar structure of ÁPhe, and (3) the isoprenyl group attached to the imidazole ring. Preliminary experiments to evaluate the bioactiviy of ÁPLH indicate this compound to inhibit tubulin polymerization (data not shown). The unique structure of ÁPLH is thought to be necessary for expression of the high inhibitory activity. Novel dehydro CDPs with potent inhibitory activity for cell division will be designed and developed based on these findings.
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